Evaluation of S-adenosyl-L-methionine production by Bifidobacterium bifidum BGN4

Food Science and Biotechnology

Volumn 17, Issue 1, 2008, Pages 184-187

  Kim, Ji Youn ^a   Suh, Joo Won ^b   Ji, Geun Eog ^a,c  

^a Seoul National University   (South Korea)

^b Myong Ji University   (South Korea)

^c Bifido Co   (South Korea)

Author keywords

Bifidobacterium bifidum BGN4; Probiotics; S adenosyl L methionine

Indexed keywords

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; LACTOBACILLUS;

EID: 49649104042     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mutai M. Characteristics of 'Mil-Mil', a Bifidobacterium-fermented milk. New Food Ind. 20: 17-20 (1978)
2. Hughes DB, Hoover DG. Bifidobacteria: Their potential for use in American dairy products. Food Technol.-Chicago 45: 64-83 (1991)
3. Kim HS. Characterization of lactobacilli and bifidobacteria as applied to dietary adjuncts. Cult. Dairy Prod. J. 23: 6-9 (1988)
4. Jayaprakasha HM, Yoon YC, Paik HD. Probiotic functional dairy foods and health claims: An overview. Food Sci. Biotechnol. 14: 523-528 (2005)
5. Lee CH. Lactic acid fermented foods and their benefits in Asia. Food Sci. Biotechnol. 8: 259-269 (1997)
6. Parvez S, Malik KA, Kang SA, Kim HY. Probiotics and their fermented food products are beneficial for health. J. Appl. Micorbiol. 100: 1171-1185 (2006)
7. Cantoni GL. S-Adenosylmethionine: A new intermediate formed enzymatically from L-methionine and adenosine triphosphate. J. Biol. Chem. 204: 403-416 (1953)
8. Lu SC. S-Adenosyl-methionine. Int. J. Biochem. Cell. B. 32: 391-395 (2000)
9. Baldessarini RJ. Neuropharmacology of S-adenosyl-L- methionine. Am. J. Med. 83: 95-105 (1987)
10. Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, McCann PP. S-Adenosylmethionine and methylation. FASEB J. 10: 471-480 (1996)
11. Friedel HA, Goa KL, Benfield P. S-Adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell membranes. Drugs 38: 389-416 (1989)
12. Bradley JD, Flusser D, Katz BP, Schumacher HR, Brandt KD, Chambers MA, Zonay LJ. A randomized double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAMe therapy in patients with knee osteoarthritis. J. Rheumatol. 21: 905-911 (1994)
13. Purohit V, Russo D. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: Introduction and summary of the symposium. Alcohol 27: 151-154 (2002)
14. Kaye GL, Blake JC, Burroughs AK. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease. Drugs 40: 124-128 (1990)
15. Lieber CS. S-Adenosyl-L-methionine: Its role in the treatment of liver disorders. Am. J. Clin. Nutr. 76: 1183-1187 (2002)
16. Gatto G, Caleri D, Michelacci S, Sicuteri F. Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: An open clinical trial. Int. J. Clin. Pharm. 6: 15-17 (1986)
17. Agnoli A, Andreoli V, Casacchia M, Cerbo R. Effect of S-adenosyl-L-methionine (SAMe) upon depressive symptoms. J. Psychiat. Res. 13: 43-54 (1976)
18. Janicak PG, Lipinski J, Davis JM, Comaty JE, Waternaux C, Cohen B, Altman E, Sharma RP. S-Adenosylmethionine in depression. A literature review and preliminary report. Ala. J. Med. Sci. 25: 306-313 (1988)
19. Jacobsen S, Danneskiold-Samsoe B, Andersen RB. Oral S-adenosylmethionine in primary fibromyalgia: Double-blind clinical evaluation. Scand. J. Rheumatol. 20: 294-302 (1991)
20. Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine. J. Neurol. Neurosurg. Ps. 53: 1096-1098 (1990)
21. Alarcon RD, Tolbert LC, Monti JA, Morere DA, Walter-Ryan WG, Kemp B, Smythie JR. One-carbon metabolism disturbances in affective disorders. A preliminary report. J. Affect. Disorders 9: 297-301 (1985)
22. Bottigliere T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 48: 137-152 (1994)
23. You HJ, Oh DK, Ji GE. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4. FEMS Microbiol. Lett. 240: 131-136 (2004)
24. Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: A modern perspective on a traditional therapy. Clin. Infect. Dis. 32: 1567-1576 (2001)
25. Payne SH, Ames BN. A procedure for rapid extraction and high-pressure liquid chromatographic separation of the nucleotides and other small molecules from bacterial cells. Anal. Biochem. 123: 151-161 (1982)
26. Lee SY, Oh SK, Park SW, Jeon GR, Kim JY, Youn SY, Ji GE. Evaluation of anti-allergic effect of bifidobacteria in murine model of peanut allergy. Pediatr. Allergy Respir. Dis. 16: 131-141 (2006)
27. Rhee JN, Lyoo YW, Choi MU. Laboratory scale preparation of S-adenosyl-L-methionine from yeast. Korean J. Appl. Microbiol. Biotechnol. 19: 588-591 (1991)
28. Kim H, Kwack K, Kim DY, Ji GE. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol. Med. Mic. 45: 259-267 (2005)